ICD-10-CM Billable Code

M08.47

Pauciarticular juvenile rheumatoid arthritis, ankle and foot

Clinical Classification Guidelines

Medical Intelligence & Overview

Pauciarticular juvenile rheumatoid arthritis (JRA) is a subtype of juvenile arthritis that primarily affects a small number of joints, typically fewer than five. When the ankles and feet are involved, it can lead to discomfort, swelling, and potential impairment in mobility for children. This condition usually occurs in children under the age of 16 and requires careful management to reduce inflammation and prevent joint damage.

Causes & Symptoms

Clinical Causes: Unknown precise cause, but most cases involve an abnormal immune response where the body's defense system mistakenly attacks its own joints. Genetic factors may play a role, with a higher likelihood of occurrence in children with a family history of autoimmune diseases. Environmental factors such as infections or exposure to certain environmental agents might trigger the immune response in genetically predisposed children. Presence of certain HLA (human leukocyte antigen) genes associated with susceptibility to autoimmune conditions.

Key Symptoms: Persistent swelling and warmth around affected ankle and foot joints. Joint stiffness, especially in the morning or after periods of rest. Pain or tenderness in the affected joints, which may worsen with activity. Reduced range of motion in the ankles and feet, potentially leading to gait disturbances. Occasional redness or swelling that is localized to the joints involved. Possible signs of mild fever or fatigue in some cases, although these are less common.

Diagnostic & Treatment

Diagnosis Path: Medical history review focusing on symptom duration, pattern, and family history. Physical examination to assess swelling, tenderness, and joint function in the ankles and feet. Laboratory tests including blood work to check for inflammation markers such as ESR or CRP. Imaging studies like X-rays or MRI scans to evaluate joint damage or inflammation without significant bone destruction. Exclusion of other joint diseases or infections that may mimic juvenile rheumatoid arthritis.

Treatment Protocols: Nonsteroidal anti-inflammatory drugs (NSAIDs) to help reduce pain and inflammation. Disease-modifying antirheumatic drugs (DMARDs) such as methotrexate to slow disease progression. Physical therapy to maintain joint flexibility and muscle strength around affected areas. Regular exercise routines tailored to avoid joint strain while promoting mobility. Use of assistive devices if necessary to support walking or joint positioning. Monitoring for potential side effects of medications and adjusting treatment plans accordingly. In some cases, corticosteroid injections may be used for quick relief of severe inflammation.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is M08.47 a billable ICD-10 code?
Yes, M08.47 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report M08.47?
Clinical documentation must specify the nature of Pauciarticular juvenile rheumatoid arthritis, ankle and foot and any associated comorbidities for accurate reporting.

Cite this Clinical Reference